Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Blue Jet Healthcare shares rally 9% after Rs 800 crore QIP allotment
Blue Jet Healthcare shares rose sharply on Friday after the company completed its Rs 800 crore QIP, attracting marquee institutional investors, including multiple ICICI Prudential Mutual Fund schemes. The fund raise is expected to strengthen the company's balance sheet, support expansion plans, and boost long-term growth prospects while broadening its institutional shareholder base.
Market ends higher: 3 factors that helped Sensex, Nifty snap two-day losing streak
Bharti Airtel, HDFC Bank and Sun Pharma were the biggest contributors to the Nifty's gains. The Nifty Bank index climbed 510 points to 57,252, while the Midcap index outperformed, rising 844 points to 62,167.
Analysts back buy-on-dips strategy as Nifty targets 24,450–24,800
Indian stock market analysts are optimistic, anticipating the Nifty to continue its upward trend. They suggest buying on dips around the 24,000-24,150 mark, with potential upside targets reaching 24,800. Several stocks, including Container Corporation of India, IndusInd Bank, Biocon, HDFC Asset Management Company, Shriram Finance, and Piramal Pharma, are highlighted as strong buy recommendations with specific price targets and stop-losses.
Sensex gains 579 points, Nifty ends above 24,150: 5 reasons why stock market rose today
Indian indices rose, Sensex up 579 pts, Nifty above 24,150, led by IT stocks, oil companies. Bank of Baroda fell on NMC Health settlement.
Sensex rises over 150 points, Nifty above 23,900 as investors weigh Iran tensions, weak monsoon concerns
Indian stock markets opened the second half of 2026 with modest gains after recent declines. Investors are closely watching escalating US-Iran tensions, which are impacting oil prices, and a concerningly weak monsoon season. Analysts suggest adjusting portfolios towards fixed income and monsoon-proof sectors like healthcare and defense to mitigate potential fallout from the dry spell.
Healthcare, banks and EVs remain long-term bets: Invesco Mutual Fund's Taher Badshah
Taher Badshah, Chief Investment Officer at Invesco Mutual Fund, expects EV adoption to increase gradually with policy support, while opportunities are emerging in power distribution alongside transmission. Badshah also said SIP inflows remain stable and mutual fund industry trends are not showing signs of concern.
HDFC Mutual Fund buys additional 10 lakh shares of Global Health for Rs 130 crore
HDFC Mutual Fund has secured an additional 10 lakh shares of Global Health, which is known for operating Medanta hospitals, from co-founder Sunil Sachdeva for Rs 130 crore. This acquisition builds on a prior purchase made last month. The transaction accounts for a 0.37% stake in the company. In related news, Global Health has reported an impressive 39.7% increase in its fourth-quarter profit after tax, totaling Rs 141.7 crore.
Stock Market LIVE: Sensex up 300 pts, Nifty above 23,850; IT, pharma & healthcare stocks lead
Sensex Today | Stock Market LIVE Updates Wednesday: In the broader markets, the Nifty MidCap and the Nifty SmallCap were trading 0.04 per cent and 0.12 per cent lower, respectively
Stock Market News Today Live Updates: Nifty Slips Below 24,050 Amid F&O Expiry, Sensex Falls Over 150 Points; Vedanta Slides 5% After Block Deals
Nifty IT and Nifty Metal fell 1.22% each, leading losses among sectoral indices. Nifty Pharma rose 0.90%, while Nifty Media gained 0.52% and Nifty India Defence advanced 0.33%.
Stocks in news: IFCI, Tata Motors, General Insurance Corp, Corona Remedies, HFCL
Markets extended their winning streak for the fourth consecutive session, driven by favorable global cues and sustained sector-wide buying. The Nifty reclaimed the 24,000 mark, approaching the 100-day EMA near 24,150. Stocks like IFCI, Tata Motors, and HFCL are in focus due to significant news developments, including IPO filings, turnaround projections, and major order wins.
HDFC MF, ADIA among buyers as Sepia Investments offloads Rs 749 crore in Corona Remedies via block deal
Sepia Investments and Anchor Partners sold shares worth about Rs 777 crore in Corona Remedies through block deals. HDFC Mutual Fund emerged as the largest buyer, while several institutional investors, including Aberdeen entities, ADIA, Invesco and WhiteOak, also accumulated stakes.
PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stake
Private equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per share. Despite this divestment, analysts remain positive on Emcure's growth outlook across its core therapeutic segments.